Cancer de la prostate

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Progres En Urologie

• Publication date

  2007-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1166-7087(07)74785-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostatic intraepithelial neoplasia: recent advances.

  2009cited by this paper
• Current prostate biopsy interpretation: criteria for cancer, atypical small acinar proliferation, high-grade prostatic intraepithelial neoplasia, and use of immunostains.

  2009cited by this paper
• Dépistage du cancer de prostate

  2008cited by this paper
• Bilan d'extension du cancer prostatique en IRM avec antenne de surface : étude prospective sur 5 ans

  2008cited by this paper
• Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer.

  2008cited by this paper
• Épidémiologie du cancer de la prostate: Article de revue

  2008cited by this paper
• First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer.

  2008cited by this paper
• Contemporary trends in low risk prostate cancer: risk assessment and treatment.

  2007cited by this paper
• Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?

  2007cited by this paper
• Endoscopic extraperitoneal radical prostatectomy : laparoscopic and robot-assisted surgery

  2007cited by this paper
• Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.

  2007cited by this paper
• Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer

  2007cited by this paper
• Concomitant and adjuvant androgen deprivation (ADT) with external beam irradiation (RT) for locally advanced prostate cancer: 6 months versus 3 years ADT--Results of the randomized EORTC Phase III trial 22961

  2007cited by this paper
• Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules.

  2007cited by this paper
• Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality.

  2007cited by this paper
• Global update on defining and treating high‐risk localized prostate cancer with leuprorelin: a USA perspective – identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy

  2007cited by this paper
• Satraplatin (S) demonstrates significant clinical benefits for the treatment of patients with HRPC: Results of a randomized phase III trial

  2007cited by this paper
• Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.

  2007cited by this paper
• ‘Insignificant’ prostate cancer on biopsy: pathologic results from subsequent radical prostatectomy

  2007cited by this paper
• The prognostic significance of perineural invasion in prostatic cancer biopsies

  2007cited by this paper
• Open radical retropubic prostatectomy.

  2007cited by this paper
• Guideline for the management of clinically localized prostate cancer: 2007 update.

  2007cited by this paper
• Cryotherapy for localised prostate cancer.

  2007cited by this paper
• The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis

  2007cited by this paper
• Pathological features after radical prostatectomy in potential candidates for active monitoring.

  2007cited by this paper
• Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy.

  2007cited by this paper
• [The frequency of cancer in France: all ages and under age 15, mortality in 2003 and trends since 1968].

  2007cited by this paper
• PixelProstate—a simple software program for the measurement of prostate cancer volume

  2007cited by this paper
• Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH.

  2007cited by this paper
• Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy.

  2007cited by this paper
• Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.

  2007cited by this paper
• Prostate specific antigen recurrence after definitive therapy.

  2007cited by this paper
• Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).

  2007cited by this paper
• Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy.

  2007cited by this paper
• Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

  2007cited by this paper
• Diffusion-weighted MRI in the body: applications and challenges in oncology.

  2007cited by this paper
• Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.

  2007cited by this paper
• Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging

  2007cited by this paper
• Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.

  2007cited by this paper
• Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance.

  2007cited by this paper
• Is the GPSM scoring algorithm for patients with prostate cancer valid in the contemporary era?

  2007cited by this paper
• Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome.

  2007cited by this paper
• Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut‐off value to predict malignancy of the peripheral zone

  2007cited by this paper
• Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.

  2007cited by this paper
• Pretreatment PSA velocity as a predictor of disease outcome following radical radiation therapy.

  2007cited by this paper
• Does active surveillance for men with localized prostate cancer carry psychological morbidity?

  2007cited by this paper
• 1388: Anatomic Localization of Prostatic Sentinel Lymph Nodes (SLN) According to Fusion Imaging of Spect and CT Scans after Intraprostatic Injection of Technetium-99M- Nanocolloid

  2006cited by this paper
• Is preoperative serum prostate‐specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?

  2006cited by this paper
• Estimates of the cancer incidence and mortality in Europe in 2006.

  2006cited by this paper
• How good is MRI at detecting and characterising cancer within the prostate?

  2006cited by this paper
• Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.

  2006cited by this paper
• Disease-specific survival following the brachytherapy management of prostate cancer.

  2006cited by this paper
• Quality control in radical (laparoscopic) prostatectomy.

  2006cited by this paper
• Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging.

  2006cited by this paper
• Combined diffusion‐weighted and dynamic contrast‐enhanced MRI for prostate cancer diagnosis—Correlation with biopsy and histopathology

  2006cited by this paper
• Survival associated with treatment vs observation of localized prostate cancer in elderly men.

  2006cited by this paper
• Androgen-deprivation therapy does not impact cause-specific or overall survival after permanent prostate brachytherapy.

  2006cited by this paper
• Laparoscopic radical prostatectomy--the experience of the German Laparoscopic Working Group.

  2006cited by this paper
• Predictors of mortality after prostate-specific antigen failure.

  2006cited by this paper
• PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time.

  2006cited by this paper
• Endorectal MR imaging before salvage prostatectomy: tumor localization and staging.

  2006cited by this paper
• Active surveillance versus radical treatment for favorable-risk localized prostate cancer

  2006cited by this paper
• Intraoperative frozen section analysis to monitor nerve-sparing radical prostatectomy.

  2006cited by this paper
• Recurrent Prostate Cancer After Radiotherapy – Salvage Treatment by High-intensity Focused Ultrasound

  2006cited by this paper
• The detection and potential economic value of complexed prostate specific antigen as a first line test.

  2006cited by this paper
• Trends and predictors of aggressive therapy for clinical locally advanced prostate carcinoma

  2006cited by this paper
• Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy.

  2006cited by this paper
• Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.

  2006cited by this paper
• Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.

  2006cited by this paper
• [Does transrectal MRI before radical prostatectomy modify the operative technique to decrease the positive margin rate?].

  2006cited by this paper
• Update on the Gleason Grading System for Prostate Cancer: Results of an International Consensus Conference of Urologic Pathologists

  2006cited by this paper
• The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer.

  2006cited by this paper
• Current practice of diagnosis and reporting of prostate cancer on needle biopsy among genitourinary pathologists.

  2006cited by this paper
• Chemoprevention of prostate cancer.

  2006cited by this paper
• Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system.

  2006cited by this paper
• Androgen‐deprivation therapy as primary treatment for localized prostate cancer

  2006cited by this paper
• Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

  2006cited by this paper
• Complications, urinary continence, and oncologic outcome of 1000 laparoscopic transperitoneal radical prostatectomies-experience at the Charité Hospital Berlin, Campus Mitte.

  2006cited by this paper
• Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).

  2006cited by this paper
• Diagnostic utility of a p63/α‐methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy

  2006cited by this paper
• Biochemical progression rates in the screen arm compared to the control arm of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer (ERSPC)

  2006cited by this paper
• Long-term functional and oncological results after retroperitoneal laparoscopic prostatectomy according to a prospective evaluation of 550 patients

  2006cited by this paper
• Histopathology reporting of prostate needle biopsies. 2005 update

  2006cited by this paper
• Risk of prostate cancer on first re-biopsy within 1 year following a diagnosis of high grade prostatic intraepithelial neoplasia is related to the number of cores sampled.

  2006cited by this paper
• Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial.

  2006cited by this paper
• Delayed versus immediate surgical intervention and prostate cancer outcome.

  2006cited by this paper
• Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10.

  2006cited by this paper
• Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

  2006cited by this paper
• The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup.

  2006cited by this paper
• Systematic review of the effect of radiation dose on tumor control and morbidity in the treatment of prostate cancer by 3D-CRT.

  2006cited by this paper
• Salvage radical prostatectomy for radiorecurrent prostate cancer: indications and results.

  2006cited by this paper
• Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings.

  2006cited by this paper
• Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE.

  2006cited by this paper
• Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.

  2006cited by this paper
• Screening for prostate cancer without digital rectal examination and transrectal ultrasound: Results after four years in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam

  2006cited by this paper
• SALVAGE THERAPY USING HIGH INTENSITY FOCUSED ULTRASOUND FOR LOCAL RECURRENCE OF PROSTATE CANCER AFTER RADIATION THERAPY

  2006cited by this paper
• Whole body MRI for detecting metastatic bone tumor: comparison with bone scintigrams.

  2005cited by this paper
• Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate.

  2005cited by this paper
• Eliminating the current Bell curve to improve the results of radical prostatectomy.

  2005cited by this paper
• Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens

  2005cited by this paper

• How do general practitioners put preventive care recommendations into practice? A cross-sectional study in Switzerland and France

  2017cites this paper
• Cancer metastase de la prostate: Aspects socio-économiques, radiologiques et évolutifs en cote d’ivoire

  2017cites this paper
• Cinétique du PSA après prostatectomie totale PSA kinetics after total prostatectomy

  2017cites this paper
• Cancers de la prostate de score de Gleason supérieur ou égal à 8: Evaluation de la survie des patients

  2016cites this paper
• La mortalité spécifique en urologie dans un hôpital de référence au Sénégal: analyse d’une série de 132 décès

  2016cites this paper
• L’adénocarcinome géant de la prostate, une présentation clinique inhabituelle

  2015cites this paper
• Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with 18F-Choline PET/CT in Prostate Cancer

  2015cites this paper
• What risk of prostate cancer led urologist to recommend prostate biopsies?

  2015cites this paper
• Epidemiology of prostate cancer in North-Ossetian Republic (Russia)

  2015cites this paper
• Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey

  2015cites this paper
• Épidémiologie du cancer de la prostate en Ossétie du Nord (Russie)

  2015cites this paper
• Treatment of the Prostate Cancer

  2015cites this paper
• Quality of life of 1276 elderly patients with prostate cancer, starting treatment with a gonadotropin-releasing hormone agonist: results of a French observational study

  2014cites this paper
• Conception et commande d'un robot de comanipulation pour l'assistance à la biopsie de prostate. (Design and control of a comanipulation robot for assistance to prostate biopsy)

  2014cites this paper
• L'UNIVERSITÉ PIERRE ET MARIE CURIE

  2014cites this paper
• Corticothérapie dans le cancer de la prostate résistant à la castration

  2013cites this paper
• Chimiothérapie des cancers de la prostate métastatiques résistants à la castration en milieu ivoirien

  2013cites this paper
• Recommandations en onco-urologie 2013 du CCAFU : Cancer de la prostate

  2013cites this paper
• [Management of prostate cancer in Senegal: what is being done?].

  2013cites this paper
• Hématurie critique post-biopsies de prostate sous RIVAROXABAN. Cas clinique Critical haematuria after prostate biopsies with RIVAROXABAN. Case report

  2013cites this paper
• Impact pronostique et thérapeutique de la différenciation neuroendocrine au sein de l’adénocarcinome prostatique: mise au point

  2012cites this paper
• A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy

  2012cites this paper
• [Recommendations for best practice for prostate biopsy].

  2011cites this paper
• Cost study of the clinical management of prostate cancer in France: results on the basis of population-based data

  2011cites this paper
• [Bone prevention in prostate cancer].

  2011cites this paper
• L'information du patient dans le dépistage du cancer de la prostate

  2011cites this paper
• Prise en charge thérapeutique des cancers de prostate

  2011cites this paper
• Prévention osseuse dans le traitement du cancer de la prostate

  2011cites this paper
• Valeur predictive du PSA dans le diagnostic du cancer de la prostate chez les sujets Beninois

  2011cites this paper
• [Radical retropubic prostatectomy (RRP) without postoperative bladder catheter: study about 14 cases].

  2011cites this paper
• Surveillance active du cancer de prostate ayant des critères de latence: les critères SURACAP sont-ils suffisants ?

  2011cites this paper
• [Prostate biopsies endothelin-1 expression: pt3a stage prognostic factor?].

  2010cites this paper
• Salvage radiotherapy after high-intensity focussed ultrasound for recurrent localised prostate cancer.

  2010cites this paper
• Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: review of technical incidents and morbidity after 5 years of use

  2010cites this paper
• Curages ganglionnaires dans les cancers de prostate et de vessie : technique et indications

  2010cites this paper
• Plants and treatment of prostatic diseases in Foumban (West Region, Cameroon)

  2010cites this paper
• [Oncologic outcomes after radical prostatectomy: French validation of the D'Amico risk group classification].

  2010cites this paper
• L’hormonothérapie anticancéreuse

  2010cites this paper
• [Urinary incontinence following open prostatectomy or laparoscopy for local prostate cancer. A review of relevant literature].

  2010cites this paper
• [Pelvic lymph nodes dissection for prostate cancer: Minilap with speculum vs laparoscopy].

  2010cites this paper
• [Update about advanced prostate cancer: diagnosis, treatment and ongoing perspectives].

  2010cites this paper
• Antibioprophylaxie courte versus longue pour les biopsies prostatiques. Étude prospective randomisée multicentrique

  2009cites this paper
• laboration dun indice de qualit anatomopathologique des biopsies prostatiques

  2009cites this paper
• [Oncologic and functional outcomes after radical prostatectomy in T3 prostate cancer].

  2009cites this paper
• Contribution à l’étude de la mortalité dans un service d’urologie: Le cas du service d’urologie du CHU de Cocody d’Abidjan de 2000 à 2006

  2009cites this paper
• Place et principes de la radiothérapie dans le cancer de la prostate du sujet âgé The role and principles of radiotherapy in prostate cancer in the elderly subject

  2009cites this paper
• La chirurgie des cancers des patients âgés présente-t-elle des particularités ?

  2009cites this paper
• Radiothérapie chez les patients à haut risque après prostatectomie radicale : postopératoire ou de rattrapage ?

  2009cites this paper
• Radiothérapie de rattrapage pour récidive biochimique après prostatectomie : comparaison entre les définitions de récidive biochimique de l’Astro et de Phoenix

  2009cites this paper
• [News aspects on surgical management of localized prostate cancer].

  2009cites this paper
• [Medical castration in the treatment of locally advanced or metastatic prostate cancer: an update].

  2009cites this paper
• Quel bilan d’imagerie avant une radiothérapie de rattrapage après prostatectomie radicale pour adénocarcinome prostatique ?

  2009cites this paper
• Analyse des résultats anatomopathologiques des pièces de prostatectomie radicale des patients répondant aux critères de surveillance active du cancer de prostate

  2009cites this paper
• La longueur des biopsies prostatiques conditionne l’identification des éléments capsulaires et périprostatiques

  2009cites this paper
• [Quality score in pathological report of prostate biopsies improve professional practice].

  2009cites this paper
• Indications de l'hormonotherapie dans le traitement du cancer de la prostate localement avancé ou metastatique Medical castration in the treatment of locally advanced or metastatic prostate cancer: an update

  2009cites this paper
• [The role and principles of radiotherapy in prostate cancer in the elderly subject].

  2009cites this paper
• [A review of bone scintigraphy in metastases from urological malignancies in adults].

  2008cites this paper
• [Prostate biopsies: how many samples and how many containers? Cost effectiveness].

  2008cites this paper
• La chirurgie du cancer de la prostate au stade localement avancé. Revue du comité de cancérologie de l'AFU (sous-comité « Prostate»)

  2008cites this paper
• [Is geriatric assessment adapted to radiotherapy?].

  2008cites this paper
• Cancer de la prostate de stade pT3 après prostatectomie totale : étude rétrospective de 246 cas Pathological stage T3 prostate cancer after radical prostatectomy: A retrospective study of 246 cases

  2008cites this paper
• [Pathological stage T3 prostate cancer after radical prostatectomy: a retrospective study of 246 cases].

  2008cites this paper
• [Trends in the management of prostate cancer over the last 20 years].

  2007cites this paper
• Diffusion-weighted MRI in the body: applications and challenges in oncology.

  2007cites this paper
• Cancer du rein et deuxième cancer : Analyse critique de la littérature

  2007cites this paper
• Le dépistage du cancer de la prostate : hétérogénéités des recommandations

  2007cites this paper
• La prostate: identification des attentes du médecin généraliste. Une enquête qualitative. Association Française d'Urologie (AFU)-IPSOS.

  2007cites this paper
• Cancer de la prostate: résumé des communications présentées au congrès American Urological Association (AUA) en 2007

  2007cites this paper
• Anxiété et cancer de la prostate À propos d’un groupe de parole de patients atteints d’un cancer de la prostate

  2007cites this paper
• Profil de tolérance du bicalutamide 150 mg (revue de la littérature et avis d'experts)

  2007cites this paper
• La ploïdie cellulaire : facteur prédictif de cancer de prostate localement avancé

  2007cites this paper
• Etude randomisée multicentrique comparant la castration médicale par triptoréline à la castration chirurgicale dans le traitement du cancer de la prostate localement avancé ou métastatique

  2007cites this paper
• [Two major diagnostic innovations in the management of prostate cancer].

  2007cites this paper
• Evolution de l'épidémiologie du cancer de la prostate depuis 20 ans

  2006cites this paper
• Cancer de la prostate à haut risque

  2006cites this paper
• [Management of positive margins after total prostatectomy for localized prostate cancer].

  2006cites this paper
• [Epidural abscess after prostatic biopsies].

  2005cites this paper
• [An experience of individual and early diagnosis of prostate cancer in a Tunisian centre].

  2005cites this paper
• How the Addition of Hormones Improves Outcome: Hormone Therapy Alone in Locally Advanced Prostate Cancer

  2004cites this paper
• Le point de vue de l’urologue

  2004cites this paper
• Cancer de prostate de forme kystique : une entité clinique de carcinome ductal

  2004cites this paper